IXICO (LON:IXI) Shares Pass Above 50 Day Moving Average – Should You Sell?

IXICO plc (LON:IXI) shares crossed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of GBX 10.25 ($0.14) and traded as high as GBX 11.80 ($0.16). IXICO shares last traded at GBX 11.16 ($0.15), with a volume of 63,833 shares.

IXICO Stock Performance

The stock has a 50-day simple moving average of GBX 10.25 and a 200 day simple moving average of GBX 10.54. The company has a debt-to-equity ratio of 3.32, a current ratio of 2.85 and a quick ratio of 4.90. The company has a market capitalization of £10.34 million, a PE ratio of -2.89, a P/E/G ratio of -0.38 and a beta of 0.86.

IXICO (LON:IXI) last issued its quarterly earnings data on Tuesday, May 20th. The company reported GBX (1.11) (($0.01)) earnings per share for the quarter. IXICO had a negative net margin of 31.10% and a negative return on equity of 19.14%. Equities analysts anticipate that IXICO plc will post -289.3584879 EPS for the current fiscal year.

Insider Transactions at IXICO

In other news, insider Grant Nash bought 45,263 shares of the firm’s stock in a transaction dated Thursday, June 12th. The stock was bought at an average price of GBX 13 ($0.17) per share, for a total transaction of £5,884.19 ($7,913.11). Insiders own 30.28% of the company’s stock.

About IXICO

IXICO is a global leader in neuroscience imaging and biomarker analytics, using its proprietary AI-driven platform to help advance the treatment of neurological disorders and reduce the uncertainties associated with drug discovery, development and monitoring.

By unlocking valuable insights into drug safety and efficacy, IXICO has built a global reputation and 20-year track record as an end-to-end Imaging Contract Research Organisation (iCRO) managing and analysing neurological clinical trials.